We've found
184,457
clinical trials
We've found
184,457
clinical trials
Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Plecanatide in Children 6 to
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Plecanatide in Children 6 to
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
A Study of RGX-202-01 With or Without FOLFIRI in Patients With Advanced Gastrointestinal Malignancies
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
A Study of RGX-202-01 With or Without FOLFIRI in Patients With Advanced Gastrointestinal Malignancies
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Pediatric Pulmonary Hypertension Clinical Trial
Updated: 12/31/1969
Actigraphy in Pediatric Pulmonary Hypertension
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Mechanical Support Measures of Adjustment and QOL
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Mechanical Support Measures of Adjustment and QOL
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Low Back Pain Clinical Trial
Updated: 12/31/1969
Meditation and Exercise to Treat Chronic Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology Clinical Trial
Updated: 12/31/1969
Metformin Gastrointestinal Intolerance: Measurement of Mitochondrial Complex I
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

PTSD Clinical Trial
Updated: 12/31/1969
Efficacy and Neural Mediators of Response to Trauma Management Therapy for PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Desmoid Tumor Clinical Trial
Updated: 12/31/1969
Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Vigil + Irinotecan and Temozolomide in Ewing's Sarcoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Vigil + Irinotecan and Temozolomide in Ewing's Sarcoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
VITROS Immunodiagnostic Products NT-proBNP II
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
VITROS Immunodiagnostic Products NT-proBNP II
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
VITROS Immunodiagnostic Products NT-proBNP II
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Sedative Adverse Reaction Clinical Trial
Updated: 12/31/1969
Evaluating the Effects of Propofol vs. Dexmedetomidine
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Inflammatory Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Inflammatory Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Inflammatory Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Inflammatory Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Inflammatory Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Other Clinical Trial
Updated: 12/31/1969
Liver, Pancreas and Thyroid Function in Burn Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Vulvodynia Clinical Trial
Updated: 12/31/1969
Dysport in Vulvodynia Phase II Study
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Pralatrexate in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphomas
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Metastatic Merkel Cell Carcinoma Clinical Trial
Updated: 12/31/1969
A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Chemotherapy and/or Metastasectomy in Treating Participants With Metastatic Colorectal Adenocarcinoma With Lung Metastases
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Chemotherapy and/or Metastasectomy in Treating Participants With Metastatic Colorectal Adenocarcinoma With Lung Metastases
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Smoking Cessation Smartphone App for Cancer Patients (Quit2Heal Study)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab After Donor Stem Cell Transplant in Treating Participants With High Risk Refractory or Relapsed Acute Myeloid Leukemia
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

PCOS Clinical Trial
Updated: 12/31/1969
An Integrated Self-Management Intervention for Adolescents With Polycystic Ovary Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety of LAIV4 in Children With Asthma
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Atezolizumab and Cobimetinib in Treating Patients With Metastatic, Recurrent, or Refractory Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Atezolizumab and Cobimetinib in Treating Patients With Metastatic, Recurrent, or Refractory Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Parkinson Disease Clinical Trial
Updated: 12/31/1969
Advancing Pre-operative Targeting for Deep Brain Stimulation in the Globus Pallidus Internus
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

B-Cell Acute Lymphoblastic Leukemia Clinical Trial
Updated: 12/31/1969
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Acute Myeloid Leukemia Clinical Trial
Updated: 12/31/1969
Milademetan Plus Quizartinib Combination Study in FLT3-ITD Mutant Acute Myeloid Leukemia (AML)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Influenza Clinical Trial
Updated: 12/31/1969
Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like Symptoms
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Influenza Clinical Trial
Updated: 12/31/1969
Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like Symptoms
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Influenza Clinical Trial
Updated: 12/31/1969
Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like Symptoms
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Click here to add this to my saved trials

Sickle Cell Disease Clinical Trial
Updated: 12/31/1969
Sickle Cell Pro-Inflammatory Response to Interval Training Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Achalasia Clinical Trial
Updated: 12/31/1969
Botox or Botox With Esophageal Dilation in Patients With Achalasia
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Effects of Digital Stories Intervention on Psychosocial Well-being
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Chemotherapy-Induced Peripheral Neuropathy Clinical Trial
Updated: 12/31/1969
Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Chemotherapy-Induced Peripheral Neuropathy Clinical Trial
Updated: 12/31/1969
Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Chemotherapy-Induced Peripheral Neuropathy Clinical Trial
Updated: 12/31/1969
Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Chemotherapy-Induced Peripheral Neuropathy Clinical Trial
Updated: 12/31/1969
Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Chemotherapy-Induced Peripheral Neuropathy Clinical Trial
Updated: 12/31/1969
Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Dermatology / Plastic Surgery Clinical Trial
Updated: 12/31/1969
Lipidome and Microbiome Profile of the Eye in Rosacea
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Safety Planning Juvenile Justice
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
